Form 4: BIO-TECHNE CFO Reports Stock Transaction
Insider Transaction (Form 4)
James Hippel, CFO of BIO-TECHNE Corp, reported multiple transactions in common stock on August 15, 2026.
Summary
- Option exercise/conversion: acquired 9,779 Common Stock on August 15, 2026; holds 174,493 after (Direct).
- Tax/exercise-price withholding: disposed of 4,310 Common Stock at $72.40 ($312,044) on August 15, 2026; holds 170,183 after (Direct).
- Option exercise/conversion: disposed of 866 Performance Restricted Stock Units on August 15, 2026; holds 12,999 after (Direct).
- Disposition to the issuer: disposed of 12,999 Performance Restricted Stock Units on August 15, 2026 (Direct).
- Disposition to the issuer: disposed of 34,982 Performance Stock Options (Right to Buy) on August 15, 2026; holds 2,332 after (Direct).
- Option exercise/conversion: disposed of 4,010 Restricted Stock Units on August 15, 2026; holds 4,011 after (Direct).
- Option exercise/conversion: disposed of 4,903 Restricted Stock Units on August 15, 2026; holds 9,807 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James Hippel — Officer (CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Option exercise/conversion | Common Stock | 9,779 | — | — | 174,493 |
| 2026-08-15 | Tax/exercise-price withholding | Common Stock | 4,310 | $72 | $312.0K | 170,183 |
| 2026-08-15 | Option exercise/conversion | Performance Restricted Stock Units | 866 | — | — | 12,999 |
| 2026-08-15 | Disposition to the issuer | Performance Restricted Stock Units | 12,999 | — | — | 0 |
| 2026-08-15 | Disposition to the issuer | Performance Stock Options (Right to Buy) | 34,982 | — | — | 2,332 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 4,010 | — | — | 4,011 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 4,903 | — | — | 9,807 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Option exercise/conversion (9,779 shares) |
| 2026-08-15 | Tax/exercise-price withholding (4,310 shares) |
| 2026-08-15 | Option exercise/conversion (866 shares) |
| 2026-08-15 | Disposition to the issuer (12,999 shares) |
| 2026-08-15 | Disposition to the issuer (34,982 shares) |
| 2026-08-15 | Option exercise/conversion (4,010 shares) |
| 2026-08-15 | Option exercise/conversion (4,903 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, James Hippel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.